On the recordFebruary 24, 2016
We are asking for a very specific carve-out for a very small exception that does not necessarily--well, it does not cost us any money.
Source
congress.govWe are asking for a very specific carve-out for a very small exception that does not necessarily--well, it does not cost us any money.
Senator Carper advocates for a specific exception in FDA regulations for terminal patients.
Share
More from Tom Carper
We will do it again. Maybe the next time we will actually make it to Columbia.
Public engagement can build trust, it can increase public buy-in, can help resolve issues, can help prevent litigation, and ultimately it can save time and money.
We are better off when we hear community concerns at the beginning of the process rather than at the end.